PT  - JOURNAL ARTICLE
AU  - Smith, Thomas P.
AU  - Dorigatti, Ilaria
AU  - Mishra, Swapnil
AU  - Volz, Erik
AU  - Walker, Patrick G. T.
AU  - Ragonnet-Cronin, Manon
AU  - Tristem, Michael
AU  - Pearse, William D.
TI  - Environmental drivers of SARS-CoV-2 lineage B.1.1.7 transmission intensity
AID  - 10.1101/2021.03.09.21253242
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.03.09.21253242
4099  - http://medrxiv.org/content/early/2021/03/19/2021.03.09.21253242.short
4100  - http://medrxiv.org/content/early/2021/03/19/2021.03.09.21253242.full
AB  - Previous work has shown that environment affects SARS-CoV-2 transmission, but it is unclear whether emerging strains show similar responses. Here we show that, like other SARS-CoV-2 strains, lineage B.1.1.7 spread with greater transmission in colder and more densely populated parts of England. However, we also find evidence of B.1.1.7 having a transmission advantage at warmer temperatures compared to other strains. This implies that spring and summer conditions are unlikely to slow B.1.1.7’s invasion in Europe and across the Northern hemisphere - an important consideration for public health interventions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by a Natural Environment Research Council grant NE/V009710/1 and by the Imperial College COVID-19 Research Fund.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not ApplicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo new data was collected for this study. The data used is archived in a github repository alongside the analysis code. https://github.com/smithtp/covid19-variant-N501Y